Tea Talks Houston with Spanios
Spanios’ proprietary method creates patient-derived 3D tumor models that are essential to optimize treatment pathways for targeted cancers. By providing a platform for validating efficacy and biomarker data, researchers and practitioners can make data-driven decisions faster than ever before. As the disease evolves or progresses, adjustments to drug regimens can be tested and the combined power of our lab validation and technology platform provides predictive treatment recommendations. At Spanios, they custom any organoid platform for any drug modality against any solid cancer indication. Founder and CSO Bhuvanesh Dave joins us to talk more about Spanios.